Nadroparin Versus TIPS in Cirrhotic Patients With Refractory Asymptomatic PVT

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
The purpose of this study is to evaluate the comparative effectiveness of nadroparin versus transjugular intrahepatic portosystemic shunt in cirrhotic patients with refractory asymptomatic portal vein thrombosis using a design of a multicenter, randomized controlled trial
Epistemonikos ID: 4f8205577de398da1ad8d030f820b6e3856867bf
First added on: May 15, 2024